VestGen Advisors LLC boosted its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 248.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,576 shares of the biotechnology company's stock after purchasing an additional 2,550 shares during the quarter. VestGen Advisors LLC's holdings in Axon Enterprise were worth $1,511,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently added to or reduced their stakes in the company. M & L Capital Management Ltd purchased a new stake in Axon Enterprise in the 3rd quarter valued at about $30,000. Generali Asset Management SPA SGR increased its stake in shares of Axon Enterprise by 2.1% during the 3rd quarter. Generali Asset Management SPA SGR now owns 2,657 shares of the biotechnology company's stock valued at $1,123,000 after acquiring an additional 55 shares during the last quarter. Asset Management One Co. Ltd. lifted its holdings in shares of Axon Enterprise by 1.4% during the 3rd quarter. Asset Management One Co. Ltd. now owns 34,607 shares of the biotechnology company's stock worth $14,622,000 after acquiring an additional 479 shares during the period. Balance Wealth Partners LLC purchased a new position in shares of Axon Enterprise during the 3rd quarter worth about $44,000. Finally, Verdence Capital Advisors LLC purchased a new position in shares of Axon Enterprise during the 3rd quarter worth about $440,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Axon Enterprise News Roundup
Here are the key news stories impacting Axon Enterprise this week:
- Positive Sentiment: An analyst opinion upgraded Axon Enterprise to “Buy,” arguing that the company’s valuation premium has narrowed and that its integrated public-safety hardware and cloud-software ecosystem continues to support strong growth. Axon Enterprise: Upgrading To Buy As The Premium Fades
- Positive Sentiment: Recent comparisons with DocuSign, Adobe and Datadog highlighted Axon’s rapid expansion in public safety and its combination of connected devices, software and recurring services. Other coverage also raised the possibility of substantial long-term upside, though these articles were opinion-based rather than new company announcements. Can Axon Stock Jump 50?
- Neutral Sentiment: Investment comparisons positioned Axon as a high-growth public-safety technology company, but offered no new financial results, contracts or guidance that would immediately change earnings expectations. Axon Enterprise vs. DocuSign
- Negative Sentiment: Investors may be reducing exposure before earnings because Zacks said Axon does not appear to have the usual combination of factors supporting a likely earnings beat. That raises the risk of volatility if results or guidance fall short of expectations. Axon Reports Next Week
- Negative Sentiment: Concerns remain that employee share-based compensation taxes are consuming cash despite strong growth, while the stock’s premium valuation leaves limited room for execution errors. Strong Growth, But Staff Share Taxes Eat The Cash
- Negative Sentiment: Axon’s larger decline than the broader market indicates near-term selling pressure, likely reflecting profit-taking and pre-earnings caution rather than a newly announced operational setback. Axon Registers a Bigger Fall Than the Market
Axon Enterprise Price Performance
AXON stock opened at $427.77 on Friday. The company has a market cap of $34.75 billion, a PE ratio of 177.50, a price-to-earnings-growth ratio of 8.33 and a beta of 1.44. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The stock has a 50-day moving average price of $463.44 and a two-hundred day moving average price of $481.21. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $749.96.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The biotechnology company reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.84 by $0.04. The company had revenue of $904.39 million for the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The company's quarterly revenue was up 35.3% compared to the same quarter last year. During the same period last year, the business posted $2.12 EPS. As a group, research analysts predict that Axon Enterprise, Inc will post 2.10 EPS for the current year.
Insider Buying and Selling at Axon Enterprise
In other news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the sale, the chief executive officer owned 3,118,012 shares of the company's stock, valued at $1,587,036,927.88. This represents a 0.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of the stock in a transaction on Friday, September 11th. The stock was sold at an average price of $480.45, for a total transaction of $488,617.65. Following the completion of the sale, the insider directly owned 56,264 shares of the company's stock, valued at $27,032,038.80. The trade was a 1.78% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 47,397 shares of company stock valued at $26,722,984. 4.20% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
AXON has been the topic of several research analyst reports. Raymond James Financial set a $675.00 target price on shares of Axon Enterprise in a research report on Thursday, October 15th. Zacks Research raised shares of Axon Enterprise from a "hold" rating to a "strong-buy" rating in a research report on Monday, October 5th. Needham & Company LLC reaffirmed a "buy" rating on shares of Axon Enterprise in a research report on Tuesday. The Goldman Sachs Group cut their price target on shares of Axon Enterprise from $715.00 to $675.00 and set a "buy" rating on the stock in a research note on Monday, September 21st. Finally, Weiss Ratings reiterated a "hold (c-)" rating on shares of Axon Enterprise in a report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $688.38.
View Our Latest Stock Report on Axon Enterprise
Axon Enterprise Company Profile
(
Free Report)
Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company's portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.
Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.
The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.